Company News Pharmaceutical Industry News
No business can ignore their Carbon Footprint, nor their responsibilities to achieve Net Zero carbon emissions. At ALLpaQ, we believe […]
Oct 05th, 2022
Oct 05th, 2022
Validation and regulatory approval are among the top concerns of biomanufacturing professionals considering implementing single-use systems, according to a survey by Pharma IQ.
Disposable Solutions for Biomanufacturing 2014 Survey Results and Insight found that 60% of respondents saw validation as their biggest challenge with single-use systems.
Other key findings include:
The Pharma IQ online survey, which was conducted during October/November 2013, gauged the priorities and investment levels of biomanufacturing professionals currently weighing up the pros and cons of single-use systems.
“With single-use technology you have multiple challenges,” the report says.
The process by which industry validates a single-use system is currently unknown. This is partially down to the fact that there is an absence of “clear” regulatory guidance for the industry.
“To address this issue various organisations are looking at paths for approval,” explains the survey. “Multiple companies are looking into integration of single-use tools/devices into closed systems. Others are also looking at automaton of single-use systems, which will, over time, resolve some of their issues around validation.”
The survey generated feedback from stakeholders around the world, casting a spotlight on the perspectives of end-users.
Visit Pharma IQ for more information